9th May, 2002
Ministry of Chemical & Fertilizer
 


SATISFACTORY AVAILABILITY OF ALLOPATHIC DRUGS AND PHARMACEUTICALS IN THE COUNTRY: S. S. DHINDSA


CONSULTATIVE COMMITTEE OF THE MINISTRY OF

CHEMICALS & FERTILIZERS MEETS

Minister for Chemicals and Fertilizers, Shri S. S. Dhindsa said that availability position of allopathic drugs and pharmaceuticals in the country is by and large satisfactory and demand is being met. There has been no report of general shortage of medicines in the country in the last two years. In the event of temporary shortage of individual drugs, substitutes of equivalent therapeutic value are available in the market, he added. Shri Dhindsa was addressing the Consultative Committee Meeting attached to the Ministry of Chemicals and Fertilizers, here today. The agenda for the meeting was "Availability and Prices of Drugs".

The members of the Consultative Committee discussed the "Pharmaceutical Policy – 2002" which was recently announced by the Government. The new Policy prescribes the span of price control on pharmaceuticals in a transparent and objective manner. According to this policy, items appearing in the National Essential Drug List of the Ministry of Health & Family Welfare and other items considered important by that Ministry from the point of view of their use in various Health Programmes in emergency care etc. (with the exclusion of sera and vaccines, blood products etc.) would form the total basket out of which selection of bulk drugs would be made for price regulation in accordance with the criteria laid down therein.

The Pharmaceutical Policy-2002 provides for monitoring of prices of decontrolled and formulation by National Pharmaceutical Pricing Authority (NPPA). The Policy proposes to strengthen the NPPA by providing appropriate powers under the DPCO which would make it mandatory for the manufacturer to furnish all information as called for by NPPA. NPPA will also have powers to regulate such prices, wherever required. The NPPA has been monitoring the prices of medicines under the price decontrolled category. Since there is a large number of medicines marketed in the country and large number of companies involved in manufacturing, the NPPA is involving State Drug Control machinery in monitoring. Shortage is monitored through a system in which the State Drug Controllers send reports to the Government as well as NPPA as and when it occurs. NPPA takes up the matter with the concerned manufacturers to rush supply to the destination concerned. The companies confirm the action taken to NPPA and the concerned State Drug Controller.

The members also discussed issues pertaining to the availability, price fixation, research and development in the pharmaceutical sector. The members who attended the meeting were Shri A. C. Jose, Shri Baju Ban Riyan and Shri Y. S. Vivekananda Reddy (Lok Sabha); Shri Manoj Bhattacharya (Rajya Sabha).